"Given the growing number of Americans at risk for this painful and often disabling disease and the availability of an effective vaccine, shingles vaccination could provide a valuable opportunity to ...

带状疱疹民间俗称“缠腰火龙、缠腰龙、蛇盘疮、蛇缠腰”，带状疱疹后神经痛 (postherpetic neuralgia, PHN) 是带状疱疹皮疹愈合后持续1个月及以上的疼痛，是带状疱疹最常见的并发症，属于后遗症的一种，可表现为持续性疼痛，也可缓解一段时间后再次出现。

Aussies who are classified as 'moderate to high risk' and are aged between 18 and 64 now qualify for the immunisation.

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

竟天（6917）16日公告，用于缓解头颈部带状疱疹后神经痛的喷雾新药APC101，于今年4月获TFDA核准启动二期临床试验后，已成功在三军总医院收治首位病患。

GSK plc (LSE/NYSE: GSK) is partnering with Brooke Shields, as part of its THRIVE@50+ campaign, to encourage people 50 and ...

竟天头颈部带状疱疹后神经痛目前并无有效的已上市药物，公司预计在完成二期临床，取得相关试验数据，将向美国FDA争取申请快速审查认定 (Fast Track Designation)或孤儿药资格认定 (Orphan Drug Designation)，推动新药及早上市，满足医疗的迫切需求。

Following the rash, a person can also experience post-herpetic neuralgia (PHN), pain lasting from at least three months up to several years. PHN is the most common complication of shingles ...

GlaxoSmithKline (GSK) has just announced that their shingles vaccine, Shingrix, is now available in Malaysia. This new vaccine aims to prevent shingles (herpes zoster, HZ), and post-herpetic neuralgia ...

Scilex’s commercial products include: (i) ZTlido® (lidocaine topical system) 1.8%, a prescription lidocaine topical product approved by the U.S. Food and Drug Administration (the “FDA”) for the relief ...